Development of scandium-exopolysaccharide complexes as a theranostic tool in bone oncology - Archive ouverte HAL
Communication Dans Un Congrès Année : 2019

Development of scandium-exopolysaccharide complexes as a theranostic tool in bone oncology

Résumé

The anti-metastatic properties of an exopolysaccharide (EPS) derivative produced by a deep-sea hydrothermal bacterium, Alteromonas infernus, were favourably evaluated on bone remodeling [1].

Domaines

Physique [physics]

INSPIRE HEP  : Connectez-vous pour contacter le contributeur

https://hal.science/hal-02317349

Soumis le : mercredi 16 octobre 2019-00:55:36

Dernière modification le : mardi 17 septembre 2024-15:55:28

Fichier non déposé

Dates et versions

hal-02317349 , version 1 (16-10-2019)

Identifiants

Citer

M. Mazza, E. Mounier, C. Alliot, C. Sinquin, P. Reiller, et al.. Development of scandium-exopolysaccharide complexes as a theranostic tool in bone oncology. 3rd International Symposium on Technetium and Other Radiometals in Chemistry and Medicine, Sep 2018, Bressanone, Italy. pp.S22-S23, ⟨10.1016/S0969-8051(19)30250-1⟩. ⟨hal-02317349⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

IN2P3 UNIV-NANTES SUBATECH CNRS IMT-ATLANTIQUE SUBATECH-RADIOCHIMIE NANTES-UNIVERSITE INSTITUT-MINES-TELECOM
42 Consultations
0 Téléchargements

Altmetric

Partager

More